| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Bernstein Jeffrey Daniel serves as a Director at PRVA. Across recent SEC filings that breaks down to 0 buys and 4 sells. Those positions are worth an estimated $2.5M at current prices.
Historically, Bernstein Jeffrey Daniel's trades have earned a middling insider score of 63/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +21.0%.
The biggest single holding is PRVA (~$2.5M) as Director. The recent filings there lean toward selling, a net 47,212,093 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 | PRVA Privia Health Group, Inc. | Director | Sell | 24,819,473 | $21.62 | $536,472,908.90 | -99.6% | -10.9% | -35.7% | |
| Nov 21, 2022 | PRVA Privia Health Group, Inc. | - | Sell | 3,186,888 | $22.56 | $71,896,193.28 | -11.4% | +21.7% | -3.6% | |
| Nov 23, 2021 | PRVA Privia Health Group, Inc. | - | Sell | 2,505,732 | $27.69 | $69,396,247.74 | -8.0% | -1.3% | -10.3% | |
| May 3, 2021 | PRVA Privia Health Group, Inc. | - | Sell | 16,700,000 | $21.62 | $361,054,000.00 | -17.4% | +16.7% | -34.5% |